Becton, Dickinson and Company Total Operating Expenses decreased by 1.7% to $4.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.8%, from $4.10B to $4.62B. Over 4 years (FY 2021 to FY 2025), Total Operating Expenses shows relatively stable performance with a 2.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A lower ratio of operating expenses to revenue indicates a more efficient and scalable business model.
Total operating expenses represent the sum of all costs incurred to run the business, including SG&A, R&D, and other ope...
Standard metric; essential for comparing operational discipline across the medical device industry.
total_operating_expenses| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.11B | $4.47B | $4.03B | $4.19B | $4.10B | $4.27B | $4.00B | $4.19B | $4.33B | $4.74B | $4.27B | $4.31B | $4.39B | $4.81B | $4.72B | $4.10B | $4.63B | $5.19B | $4.70B | $4.62B |
| QoQ Change | — | +8.6% | -9.9% | +3.9% | -1.9% | +4.1% | -6.3% | +4.8% | +3.2% | +9.4% | -9.9% | +1.0% | +1.8% | +9.7% | -2.1% | -13.1% | +12.9% | +12.3% | -9.5% | -1.7% |
| YoY Change | — | — | — | — | -0.2% | -4.4% | -0.6% | +0.2% | +5.5% | +10.9% | +6.6% | +2.8% | +1.4% | +1.6% | +10.5% | -5.0% | +5.4% | +7.9% | -0.3% | +12.8% |